Regulation of Complement C3 Expression by the Bile Acid Receptor FXR
Open Access
- 1 March 2005
- journal article
- Published by Elsevier BV
- Vol. 280 (9), 7427-7434
- https://doi.org/10.1074/jbc.m411473200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Polyunsaturated Fatty Acids Are FXR Ligands and Differentially Regulate Expression of FXR TargetsDNA and Cell Biology, 2004
- Lack of Complement Factor C3, but Not Factor B, Increases Hyperlipidemia and Atherosclerosis in Apolipoprotein E−/− Low-Density Lipoprotein Receptor−/− MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic inductionDevelopmental Biology, 2004
- Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional ActivationJournal of Biological Chemistry, 2003
- The Farnesoid X-receptor Is an Essential Regulator of Cholesterol HomeostasisJournal of Biological Chemistry, 2003
- Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.Diabetes Care, 2000
- Increased Expression of Complement Component C3 in the Plasma of Obese Zuckerfaand LA/NfefRats Compared with Their Lean CounterpartsObesity Research, 1998
- Analysis of complement C3 activation products in human atherosclerotic lesionsAtherosclerosis, 1991
- The effects on complement component 3 of dietary variation of protein, fat and vitamin E during growth of young miceLife Sciences, 1989
- Chenodeoxycholic AcidDrugs, 1981